ADRB2 and heart failure: As many elements of the cardiac β-AR signal transduction cascade exhibit an altered expression in congestive heart failure and many clinically used β-AR antagonists exhibit various degrees of IA, it has been speculated that the presence of IA may at least partly explain different outcomes upon the treatment of heart failure patients with different β-AR antagonists [153].